Neuronetics Inc
NASDAQ:STIM
Neuronetics Inc
Revenue
Neuronetics Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Neuronetics Inc
NASDAQ:STIM
|
Revenue
$71.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.2B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$20.5B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Neuronetics Inc
Revenue Breakdown
Breakdown by Geography
Neuronetics Inc
Total Revenue:
71.3m
USD
|
United States:
69.3m
USD
|
International:
2m
USD
|
Breakdown by Segments
Neuronetics Inc
See Also
What is Neuronetics Inc's Revenue?
Revenue
71.3m
USD
Based on the financial report for Dec 31, 2023, Neuronetics Inc's Revenue amounts to 71.3m USD.
What is Neuronetics Inc's Revenue growth rate?
Revenue CAGR 5Y
6%
Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Neuronetics Inc have been 13% over the past three years , 6% over the past five years .